CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells

This study reports the CD44 receptor-targeted gold-doxorubicin nanocomposite ((T)GNC-DOX) for pulsatile chemo-photothermal therapy of triple-negative breast cancer (TNBC). The developed (T)GNC-DOX was nanometric, having a particle size of 71.34 ± 3.66 nm. The doxorubicin was loaded by electrostatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalyane, Dnyaneshwar, Polaka, Suryanarayana, Vasdev, Nupur, Tekade, Rakesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787590/
https://www.ncbi.nlm.nih.gov/pubmed/36559228
http://dx.doi.org/10.3390/pharmaceutics14122734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787590/
https://www.ncbi.nlm.nih.gov/pubmed/36559228
http://dx.doi.org/10.3390/pharmaceutics14122734

Ejemplares similares